Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Gaughran

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Psychological Medicine|March 23, 2023
Cannabis use and psychotic disorders in diverse settings in the Global South: findings from INTREPID IIJoni Lee Pow, Casswina Donald, Marta di Forti, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 26, 2018
Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trialRichard I G Holt, Rebecca Gossage-Worrall, Daniel Hind, et al.
Health Technology Assessment (Winchester, England)|December 1, 2018
Structured lifestyle education to support weight loss for people with schizophrenia, schizoaffective disorder and first episode psychosis: the STEPWISE RCTRichard Ig Holt, Daniel Hind, Rebecca Gossage-Worrall, et al.
Biological Psychiatry|October 22, 2016
An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode PsychosisEvangelos Vassos, Marta Di Forti, Jonathan Coleman, et al.
The Lancet. Psychiatry|August 14, 2025
Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health CommissionSean Halstead, Chloe X Yap, Nicola Warren, et al.
Plos One|March 23, 2013
Harnessing clinical psychiatric data with an electronic assessment tool (OPCRIT+): the utility of symptom dimensionsPhilip James Brittain, Sarah Elizabeth Margaret Lobo, James Rucker, et al.
The Lancet. Psychiatry|July 21, 2019
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illnessJoseph Firth, Najma Siddiqi, Ai Koyanagi, et al.
JAMA Psychiatry|November 16, 2022
Epidemiology of Untreated Psychoses in 3 Diverse Settings in the Global South: The International Research Program on Psychotic Disorders in Diverse Settings (INTREPID II)Craig Morgan, Alex Cohen, Georgina Miguel Esponda, et al.
Elife|March 1, 2021
DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophreniaEilis Hannon, Emma L Dempster, Georgina Mansell, et al.
The American Journal of Psychiatry|December 7, 2016
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and TerminologyOliver D Howes, Rob McCutcheon, Ofer Agid, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Psychological Medicine|March 23, 2023
Cannabis use and psychotic disorders in diverse settings in the Global South: findings from INTREPID IIJoni Lee Pow, Casswina Donald, Marta di Forti, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 26, 2018
Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trialRichard I G Holt, Rebecca Gossage-Worrall, Daniel Hind, et al.
Health Technology Assessment (Winchester, England)|December 1, 2018
Structured lifestyle education to support weight loss for people with schizophrenia, schizoaffective disorder and first episode psychosis: the STEPWISE RCTRichard Ig Holt, Daniel Hind, Rebecca Gossage-Worrall, et al.
Biological Psychiatry|October 22, 2016
An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode PsychosisEvangelos Vassos, Marta Di Forti, Jonathan Coleman, et al.
The Lancet. Psychiatry|August 14, 2025
Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health CommissionSean Halstead, Chloe X Yap, Nicola Warren, et al.
Plos One|March 23, 2013
Harnessing clinical psychiatric data with an electronic assessment tool (OPCRIT+): the utility of symptom dimensionsPhilip James Brittain, Sarah Elizabeth Margaret Lobo, James Rucker, et al.
The Lancet. Psychiatry|July 21, 2019
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illnessJoseph Firth, Najma Siddiqi, Ai Koyanagi, et al.
JAMA Psychiatry|November 16, 2022
Epidemiology of Untreated Psychoses in 3 Diverse Settings in the Global South: The International Research Program on Psychotic Disorders in Diverse Settings (INTREPID II)Craig Morgan, Alex Cohen, Georgina Miguel Esponda, et al.
Elife|March 1, 2021
DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophreniaEilis Hannon, Emma L Dempster, Georgina Mansell, et al.
The American Journal of Psychiatry|December 7, 2016
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and TerminologyOliver D Howes, Rob McCutcheon, Ofer Agid, et al.
Pageof 19